Dabigatran Etexilate 75 mg capsules recalled for N-nitroso impurity
Ascend Laboratories is recalling Dabigatran Etexilate 75 mg capsules nationwide due to manufacturing deviations. Three lots contain N-nitroso-Dabigatran impurity above recommended interim limits.
- Product
- DABIGATRAN ETEXILATE — DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE)
- Category
- Drug
- Distribution
- Distributed nationwide